Two immunologists, James Allison from the University of Texas Austin and Tasuku Honjo from Kyoto University, have won the 2018 Nobel Medicine Prize for research that has revolutionised the treatment of cancer. The pair were honoured'for their discovery of cancer therapy by inhibition of negative immune regulation,' the Nobel Assembly said. Immune checkpoint inhibitor therapy targets proteins made by some immune system cells, as well as some cancer cells. The proteins can stop the body's natural defences from killing cancer cells. The therapy is designed to remove this protein'brake' and allow the immune system to more quickly get to work fighting the cancer.
Oct-1-2018, 12:35:12 GMT